Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer Posted by By Mourabit Halima 2025.07.01
HER2-targeted Efficacy Prediction Model Based on Gastric Cancer Microenvironment Characteristics Posted by By Lisa Cui 2025.07.01
Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer Posted by By Mourabit Halima 2025.07.01
Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer Posted by By Lisa Cui 2025.07.01
Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer Posted by By Ren Jiamo 2025.07.01
Early research, clinical practice and thinking of innovative NK cell therapy Posted by By Mourabit Halima 2025.07.01
